Table 4 Multidisciplinary team (MDT) decision-making for adjuvant therapy

From: The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study

MDT decision-making per patient

All patients (n = 2540)

Mastectomy only (n = 1532)

Implant (n = 675)

Pedicled flap (n = 105)

Free-flap (n = 228)

P-value

Chemotherapy

  Recommended by MDT

649 (25.6)

421 (27.5)

154 (22.8)

28 (26.7)

46 (20.2)

<0.001

  For discussion with patient

188 (7.4)

138 (9.0)

36 (5.3)

5 (4.8)

9 (3.9)

 

  For oncotype DX testing

181 (7.1)

95 (6.2)

64 (9.5)

5 (4.8)

17 (7.5)

 

  Not recommended by MDT

1509 (59.4)

872 (56.9)

415 (61.5)

67 (63.8)

155 (68.0)

 

  Not reported

13 (0.5)

6 (0.4)

6 (0.9)

0 (0.0)

1 (0.4)

 

Radiotherapy

  Recommended by MDT

909 (35.7)

614 (40.1)

198 (29.3)

35 (33.3)

62 (27.2)

<0.001

  For discussion with patient

125 (4.9)

86 (5.6)

19 (2.8)

1 (1.0)

19 (8.3)

 

  Not recommended by MDT

1492 (58.7)

828 (54.0)

449 (66.5)

69 (65.7)

146 (64.0)

 

  Not reported

14 (0.5)

4 (0.3)

9 (1.3)

0 (0.0)

1 (0.4)

 

Patient accepts adjuvant treatment (either chemotherapy or radiotherapy or both)

1235 (48.6)

804 (52.5)

288 (42.7)

50 (47.6)

93 (40.8)

<0.001

Time from last oncological procedure to first adjuvant treatment (days) median (IQR) (n = 1131)

53 (41–65)

52 (41–66)

51 (41–63)

57 (42–73)

57 (46–72)

0.026

Chemotherapy as 1st adjuvant treatment

627 (55.4)

409 (55.4)

147 (56.5)

25 (52.1)

46 (54.1)

0.939

Time from last oncological procedure to 1st chemotherapy (days) median (IQR)

47 (37–59)

47 (37–59)

46 (35–57)

46 (39–58)

57 (41–70)

0.063

Reported delays of >90 days of planned chemotherapy (n = 637)

31 (4.9)

21 (5.1)

4 (2.7)

3 (11.5)

3 (6.5)

0.228

Radiotherapy as 1st adjuvant treatment

504 (44.6)

329 (44.6)

113 (43.5)

23 (47.9)

39 (45.9)

0.939

Time from last oncological procedure to 1st radiotherapy (days) median (IQR)

60 (48–73)

59 (48–73)

60 (45–68)

63 (53–85)

62 (50–76)

0.248

Reported delays of >56 days (8 weeks) of planned radiotherapy (n = 616)

389 (63.2)

258 (62.8)

83 (61.9)

23 (79.3)

25 (59.5)

0.308